ArticleTalanta2016
Water dispersion of magnetic nanoparticles with selective Biofunctionality for enhanced plasmonic biosensing.
Article in Talanta, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Synthesis and Characterization of FeNanomaterials (Basel, Switzerland) · 2021Article
- Recent Trends in Electrochemical Sensors for Vital Biomedical Markers Using Hybrid Nanostructured Materials.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020Review
- Article
- Nanomaterials for Healthcare Biosensing Applications.Sensors (Basel, Switzerland) · 2019Review
- Magnetic Graphene Oxide Nanocarrier for Targeted Delivery of Cisplatin: A Perspective for Glioblastoma Treatment.Pharmaceuticals (Basel, Switzerland) · 2019Article
- Microgel assisted Lab-on-Fiber Optrode.Scientific reports · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Magnetic nanoparticles (MNPs) are widely used in biosensing, bioimaging, and drug delivery. However, high quality superparamagnetic nanoparticles with uniform size were usually synthesized by thermal decomposition using organic solvents. To be suitable for biomedical applications, a facile and efficient water dispersion of iron oxide MNPs from solvent using an innovative agent, sodium oleate (NaOL) was described. The monodispersed MNPs (4 and 15nm respectively) after transfer was biocompatible and stable at a broad temperature range (4-50°C) over months. More importantly, the NaOL coating allows for surface modification with selective functionality, rendering the aqueous MNPs highly customizable for biofunctionalization. Little effect on the superparamagnetism was observed after the water dispersion. To further evaluate its practical application in biosensing, custom MNPs were prepared for specific cardiac troponin I (cTnI) detection for myocardial infarction diagnosis. Specifically, gold nanorod (GNR) biochip was probed by the MNP-captured cTnI target analyte at varying concentrations. The signal transduction of the GNR sensor is based on the localized surface plasmon resonance (LSPR). The application of the MNPs resulted in a significant enhancement of the plasmonic response of the GNRs. As such, the MNP-mediated LSPR biosenisng showed a three times lower sensitivity as compared to the direct cTnI binding without functional MNPs. Computer simulation further elucidated that the enhancement was distance dependent between the MNP and the surface of the nanorod, which corroborated with experimental results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.